Timeline
Dated events in the published records, newest first: regulatory decisions, guideline recommendations and editions, study dates from their registries and milestones that happened. Each date is shown as precisely as its record states it.
2015 19
-
Supplemental approval Empagliflozin (Jardiance)
-
Supplemental approval Empagliflozin (Jardiance)
-
Approval SAPIEN 3 transcatheter heart valve
-
Results first posted PROTECT AF Registry does not say if reached
-
Supplemental approval Dapagliflozin (Farxiga)
-
Approval Melody transcatheter pulmonary valve
2014 14
-
Study completion CHAMPION trial
-
Primary completion IMPROVE-IT (ezetimibe added to simvastatin after acute coronary syndrome)
-
Supplemental approval Apixaban (Eliquis)
-
Approval Empagliflozin (Jardiance)
-
Study start China Salt Substitute and Stroke Study (SSaSS)
-
Approval CardioMEMS HF System
-
Study completion PARADIGM-HF
-
Primary completion PARADIGM-HF
-
Study completion PROTECT AF
-
Supplemental approval Dabigatran (Pradaxa)
-
Supplemental approval Apixaban (Eliquis)
-
Approval Dapagliflozin (Farxiga)
2013 6
-
Approval MitraClip
-
Primary completion PROTECT AF
-
Results first posted ARISTOTLE Registry does not say if reached
-
Results first posted CHAMPION trial Registry does not say if reached
2012 7
-
Approval Apixaban (Eliquis)
-
Approval Subcutaneous ICD (S-ICD) system
-
Primary completion Look AHEAD: intensive lifestyle intervention in type 2 diabetes
-
Study start COAPT trial
-
Results first posted ROCKET AF Registry does not say if reached
-
Study start ISCHEMIA (initial invasive or conservative strategy for stable coronary disease) Registry does not say if reached
2011 4
-
Approval Rivaroxaban (Xarelto)
-
Study completion ARISTOTLE
-
Primary completion ARISTOTLE
-
Results first posted RE-LY Registry does not say if reached
2010 7
-
Approval Dabigatran (Pradaxa)
-
Study completion ROCKET AF
-
Primary completion ROCKET AF
-
Study start EMPA-REG OUTCOME: empagliflozin and cardiovascular outcomes in type 2 diabetes Registry does not say if reached
-
Primary completion CHAMPION trial
2009 2
-
Study start PARADIGM-HF Registry does not say if reached
-
Primary completion RE-LY
2008 3
2007 1
-
Study start CHAMPION trial Registry does not say if reached
2006 2
2005 4
-
Study start RE-LY
-
Study completion SCD-HeFT
-
Study start PROTECT AF Registry does not say if reached
2003 1
-
Study start HF-ACTION Registry does not say if reached
2002 2
-
Study completion DASH-Sodium
-
Primary completion DASH-Sodium
2001 2
-
Approval Amplatzer Septal Occluder
2000 1
-
Clearance Omron HEM-907 blood pressure monitor
1997 2
-
Study start SCD-HeFT Registry does not say if reached
-
Study start DASH-Sodium Registry does not say if reached